The office of information management technology (OIMT) purpose of this BPA call is to provide program management support for the enterprise transformation office (ETO) to support its objectives. ETO…

Ended Awarded Last action

Contract number
75F40122F19002
Awardee
Awarding agency
Obligated
$4,351,415

Award facts

Opportunity
  • 75F40122Q00004 Solicitation number
Contract value 100% obligated
$4,351,414.94 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20903, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$624,379
Exercise an Option P00002 · Exercise OY1 & skill mix RE-alignment - ETO program support $2,520,925
Other Administrative Action P00001 · IPP modification $0
Original award $2,454,868

About this award

The Food and Drug Administration issued a BPA call to Accenture Federal Services LLC under the General Services Administration Multiple Award Schedule, with a ceiling value of $4,351,414.94 and an award date of December 10, 2021. The call supports the Office of Information Management Technology's Enterprise Transformation Office, delivering program management services to drive business process changes across FDA. Performance occurs in Silver Spring, Maryland, with an ultimate completion date of June 12, 2024.

Government invoicing through fiscal year 2024 totaled $4.595 million across 27.8 FTEs and 37,170 contractor hours. The derived blended hourly rate rose from $113.52 per hour in FY2022 to $147.24 per hour in FY2024. Most recent fiscal year (FY2024) activity reflects 2.6 FTEs and 5,402 contractor hours, self-performed by the prime with no subcontractors reported.

Description

The office of information management technology (OIMT) purpose of this BPA call is to provide program management support for the enterprise transformation office (ETO) to support its objectives. ETO will be driving business process changes across FDA

Quick answers

Who was awarded contract 75F40122F19002?

75F40122F19002 was awarded to Accenture Federal Services LLC by Food and Drug Administration (Department of Health and Human Services) on December 10, 2021.

How much is contract 75F40122F19002 worth?

The government has obligated $4,351,415 on 75F40122F19002.

Is contract 75F40122F19002 an order under another contract?

Yes. 75F40122F19002 is a BPA call under GS35F540GA-75F40121A00001, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40122F19002 competed?

The extent of competition for 75F40122F19002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award